Drug Identity
Active Ingredient
Nalbuphine
Drug Class
Pain Management
How to Take It
Dosage information not available for this product.
Safety Alerts
Acute respiratory depression, comatose patients, head injury and raised intracranial pressure (opioid analgesics interfere with pupillary responses vital for neurological assessment), risk of paralytic ileus
Important Warnings
Renal or hepatic impairment, adrenocortical insufficiency and hypothyroidism (reduced dose), asthma (avoid during an acute attack), convulsive disorders, diseases of the biliary tract, hypotension, elderly and debilitated patients (reduced dose), impaired respiratory function (avoid in chronic obstructive pulmonary disease), inflammatory bowel disorders, myasthenia gravis, obstructive bowel disorders, prostatic hypertrophy, shock, urethral stenosis, history of opioid abuse
Side Effects
Biliary spasmbradycardiaconfusionconstipationdependencedifficulty with micturitiondizzinessdrowsinessdry mouthdysphoriaeuphoriaflushinghallucinationsheadachehypotension and muscle rigidity (larger doses)
Drug Interactions
CNS depressants.
Pregnancy & Lactation
Pregnancy
Positive evidence of risk: Respiratory depression and withdrawal symptoms in the neonate; gastric stasis and inhalation pneumonia in the mother if opioid analgesics are used during labour and
Lactation
Caution advised
Price Intelligence
Rs 84.12
DVAGO observed price · as of 30 July 2026
Rs 84.12 per unit
No approved ceiling matched to this exact pack and strength.
Prices across sources
ServaidRs 569.9
DVAGORs 84.12
Should you consider an alternative?
Other options containing Nalbuphine, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
339
brands
413
molecules
1
alerts